We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

137 hedge funds and large institutions have $396M invested in iTeos Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 39

1.81% more ownership

Funds ownership: 99.18% → 100.99% (+1.8%)

2% more capital invested

Capital invested by funds: $389M → $396M (+$7.2M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 144 → 137 (-7)

14% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 36

86% less call options, than puts

Call options by funds: $2.04M | Put options by funds: $14.1M

Holders
137
Holders Change
-7
Holders Change %
-4.86%
% of All Funds
2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
48
Reduced
39
Closed
36
Calls
$2.04M
Puts
$14.1M
Net Calls
-$12M
Net Calls Change
-$16.3M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$19.8M
2
EC
EcoR1 Capital
California
+$11.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$3.02M
4
Citigroup
Citigroup
New York
+$2.56M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$10.2M
2
BlackRock
BlackRock
New York
-$7.82M
3
CS
Candriam SCA
Luxembourg
-$5.6M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.48M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$3.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
LC
126
Lindbrook Capital
California
$3.01K +$307 +31 +13%
AF
127
Allworth Financial
California
$2.49K +$1.99K +201 +773%
GI
128
GAMMA Investing
California
$1.32K +$1.32K +133 New
Carson Wealth (CWM LLC)
129
Carson Wealth (CWM LLC)
Nebraska
$1K -$2.18K -220 -62%
Daiwa Securities Group
130
Daiwa Securities Group
Japan
$1K – – –
AW
131
Avion Wealth
Texas
$1K +$535 +54 New
HFS
132
Hantz Financial Services
Michigan
$1K +$991 +100 New
PNC Financial Services Group
133
PNC Financial Services Group
Pennsylvania
$646 -$22.1K -2,228 -97%
FFA
134
Farther Finance Advisors
California
$274 +$248 +25 New
PA
135
Parallel Advisors
California
$120 +$109 +11 New
CS
136
Candriam SCA
Luxembourg
– -$5.6M -511,537 Closed
Janus Henderson Group
137
Janus Henderson Group
United Kingdom
– -$5.48M -500,324 Closed
BBA
138
Baker Bros. Advisors
New York
– -$1.65M -150,346 Closed
Los Angeles Capital Management
139
Los Angeles Capital Management
California
– -$1.16M -105,554 Closed
OCA
140
Octagon Capital Advisors
New York
– -$1.12M -102,000 Closed
Verition Fund Management
141
Verition Fund Management
Connecticut
– -$1.04M -94,824 Closed
Rafferty Asset Management
142
Rafferty Asset Management
New York
– -$933K -85,189 Closed
UOC
143
UBS O'Connor
Illinois
– -$654K -59,764 Closed
WG
144
Winton Group
United Kingdom
– -$366K -33,433 Closed
Public Sector Pension Investment Board (PSP Investments)
145
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$358K -32,728 Closed
Allianz Asset Management
146
Allianz Asset Management
Germany
– -$353K -32,200 Closed
New York State Teachers Retirement System (NYSTRS)
147
New York State Teachers Retirement System (NYSTRS)
New York
– -$298K -27,200 Closed
Thrivent Financial for Lutherans
148
Thrivent Financial for Lutherans
Minnesota
– -$265K -24,223 Closed
TPSF
149
Texas Permanent School Fund
Texas
– -$242K -22,109 Closed
YCM
150
Yousif Capital Management
Michigan
– -$232K -21,143 Closed
3 4 5
6
7

ITOS Hedge Fund Activity: Q4 2023 in Review

137 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q4 2023, worth a combined $396M — up 1.9% from $389M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ITOS and 31 opened new positions — a net loss of 5 holders — while 39 trimmed existing stakes and 48 added.

The largest buyer was Morgan Stanley, adding an estimated $19.8M. The largest seller was State Street, cutting an estimated $10.2M.

  • 137 institutional investors held iTeos Therapeutics (ITOS) as of Q4 2023, down from 144 in Q3 2023.
  • Funds reported $396M of iTeos Therapeutics stock for Q4 2023, up 1.9% quarter-over-quarter.
  • 31 funds opened new iTeos Therapeutics positions in Q4 2023 and 36 closed out, a net change of -5 holders.
  • The largest iTeos Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $19.8M added.
  • The largest iTeos Therapeutics seller in Q4 2023 was State Street, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2023.